Dr. J. Robin Conway M.D. Practices Diabetes Care in a small Ontario Town.
He is Medical Director of the Canadian Centre for Research on Diabetes carrying on clinical research on diabetes.
Dr. Conway says, "I feel my mission is in helping to educate the family physicians who treat diabetes about the disease and current treatment standards.
he is author of the booklet on Type 2 Diabetes, a Manual for Health Professionals of which 15,000 copies have been distributed to physicians in Canada along with a number of other educational supplements and research papers. Dr. Conway has served the Canadian Diabetes Association as an adviser for Canadian Diabetes Association Clinical Practice Guidelines and has served in that capacity for over 12 years. I first met Dr Conway at the Canada Diabetes Association Prefessionals Conference in Vancouver, BC. Since then I have communicated with him several times by phone and email. he, like I and a small but growing number of people are very concerned about the growing Type 2 diabetes epedemic that sweeping the world and stressing the health care delivery systems.
Dr. Conway is Associate editor of Canadian Diabetes, a journal for health professionals of the Canadian Diabetes Association.
Dr J Robin Conway M.D. Associate Editor, Canada Diabetes Association professionals Journal
Dr. Conway is one of canada's leading experts on diabetes and is an invited speaker at medical conferences.
CANADIAN CENTRE for RESEARCH on DIABETES
His website is:www.diabetesclinic.ca
Education:
Primary: England Secondary: Ashbury College, Ottawa University: University of London, England, Pre-Medical
University of Ottawa, M.D. 1972 Post Graduate: Ottawa General Hospital
Residency in Internal Medicine 1973
Licensing:
LMCC 1973 No 35,294
College of Physicians & Surgeons of Ontario Lic 25809
Professional Liability Insurance: CMPA Reg No. 120138
No previous or outstanding history of disciplinary or malpractice actions
Professional Associations:
- Ontario Medical Assoc
- Canadian Medical Association
- American Diabetes Association
- Canadian Diabetes Association; member of the Clinical & Scientific Section, Associate Editor Canadian Diabetes
- Canadian Society of Endocrinology & Metabolism
- European Association for the Study of Diabetes
- International Diabetes Federation
- Ontario Coroners Association
- Canadian Association of Aviation Medical Examiners
Hospital Affiliation:
- Perth & Smiths Falls Community Hospitals (Active Staff)
- Sault Area Hospitals (Consultant Staff)
- Rideau Regional Centre, Smiths Falls (Consultant Staff)
Medical Practice:
Diabetes Clinic, Referral Practice limited to Diabetes Mellitus. (See address and phone number above)
Special Interests:
- Intensive Management of Diabetes
- Insulin Pumps
- Clinical Research
- Medical Education of Family Practitioners
- Educational Web Site (www.diabetesclinic.ca)
Research Studies Completed:
- Zestril (Lisinopril) Post Marketing Studies 1990
- Diamicron (Gliclazide) Post Marketing Studies 1985
- Diascan Study 1999, published Diabetes Care
- AZA3002 Telmisarten in Hypertension 2000-2001
- Avandia Outcomes Study 2000-2001
- Rosiglitazone in Family Practice 2000-2001
- Wyeth-Ayerst PTP 112 2002 (Phase 2) Aldose Recuctase
- Aventis HOE901/3502
- GSK-Avandia 137 (Rosiglitazone & Microalbuminuria)
- BMS –298585
- Astra-Zeneca POLARIS
- COSMOS
- Avandaryl
- Conjuchem DM 100-102 GLP-1
- DREAM Study 2001-2006 Diabetes Prevention with Ramipril & Rosiglitazone
- ORIGIN Study Diabetes Prevention with Glargine
- Pfizer Inhaled Insulin Therapy
- CHRC-VP Registry
- PREDICTIVE (Insulin Determir)
- Astra-Zeneca G-PLUS (Tesaglitazar)
- Novolin Pen 4 Clinical Experience
- Astra-Zeneca Gallant 8 & GALLEX (Tesaglitazar
- Astra-Zeneca RELIEF (Diabetic Neuropathy
Current Research Studies:
- Navigator Study 2001-2006, Diabetes Prevention, Valsarten & Nateglinide
- GSK-ACME
- GSK-ADG20001
- Astra-Zeneca JUPITER
- ACCESS (Lilly)
- DECIDE (Pfizer)
- AVALANCHE Study (GSK & Canadian Heart Research Centre)
- GUIDE (Canadian Heart Research Centre)
- METABOLIC (Merck Frosst)
Publications:
- E Coli H-157 in Nursing Home Patients: J Inf Dis 1992
- The Case of the Exploding Cop: Diabetes Monitor 1998 (2)305
- Rosiglitazone in Family Practice: Diabetes, June 2001, Suppl
- Insulin Resistance in Diabetes Mellitus, Medical Post, Nov 2001, Suppl
- Rosiglitazone in Family Practice, Cdn J Diabetes Care, meeting suppl, Oct 2001 (abstract)
- Option or Essential Tool? Insulin Pump Therapy in Young Women: Diabetes, June 2002, Suppl
- Guidelines, Do They Make a Difference? Canadian Journal of Diabetes. 2002;26(suppl):256.
- Community Based Insulin Pump Program Outcomes. Canadian Journal of Diabetes. 2002;26(suppl);272.
- Pioglitazone in Family Practice. Canadian Journal of Diabetes. 2002;26(suppl);308.
- Rosiglitazone in Family Practice. Canadian Journal of Diabetes. 2002;26 (suppl);308
- A Community Based Insulin Pump Program. Diabetes. 2003;52 (Suppl 1) A518 Abstract 2246-PO
- Effectiveness of Rosiglitazone in Family Practice in Canada. Diabetes & Metabolism 2003,29,4S246, Abstract 2274
- Practical Application of Rosiglitazone in Clinical Practice. Diabetes & Metabolism 2003,29,4S246, Abstract 22772
- 2003 CDA Clinical Practice Guidelines, are they achievable. Canadian Journal of Diabetes 2003 Sept (Abstract)
- New Issues in the Management of Hypertension. Medical Post 2003, Suppl
- Type 2 Diabetes, A Family Physicians Guide, 2004
- Practical Application of Rosiglitazone in Clinical Practice. Diabetes 2004 June, Vol 53, Suppl 1 A121 (Abstract)
- Diabetes Flow Sheet with Feedback to Improve CPG Compliance. Canadian Journal of Diabetes. 2004 Sep, Vol 28 No 3, P 314
- Peri-Op & Peri-ACS Glucose Control. Canadian Diabetes, 18(2),Summer 2005 (Editorial)
- Type 2 Diabetes, A Health Professional's Guide, 2006
- Sexual Dysfunction in Diabetes. Canadian Diabetes. 19(1), Spring 2006 (Editorial)
- A Randomized Trial of Adding Insulin Glargine vs avoidance of Insulin in People with Type 2 Diabetes on either no oral glucose lowering agents or submaximal doses of Metformin and/or Sulphonylureas. The Canadian INSIGHT Study. Diabetic Medicine. 2006;
- Hypertension & Diabetic Retinopathy. Medical Post. 20 June 2006, Suppl
- Aggressive Cardiovascular Treatment Needed for People with Diabetes. Canadian Diabetes Vol 19, No 3, 2006 (Editorial)
- Necessite d'un traitment cardio-vasculaire energique en presence de diabete. Canadian Diabetes Vol 19, No 3, 2006 (Ed)
- Advances in management options for insulin-dependent patients. The Medical Post. 12 June 2007; 43(21):(center-fold)
Presentations: (Recent)
- Insulin Pump Therapy in Young Women: ADA June 2002, San Francisco
- Community Based Insulin Pump Outcomes: CDA Oct 2002, Vancouver
- Pioglitazone in Family Practice: CDA Oct 2002, Vancouver
- Rosiglitazone in Family Practice: CDA Oct 2002, Vancouver
- Guidelines, Do They Make a Difference: CDA Oct 2002, Vancouver
- A Community Based Insulin Pump Program: ADA June 2003, New Orleans
- Application of Rosiglitazone In Clinical Practice: IDF 2003, Paris, France
- 2003 CDA Clinical Practice Guidelines, are they achievable: CDA 2003, Ottawa
- Rosiglitazone in Clinical Practice, ADA June 2003
- Diabetes Flow Sheet. CDA, Oct 2004, Quebec City
- CPG Guidelines, CDA, Oct 2004, Quebec City, Satellite Symposium
- Review of Insulin Pump Therapy, NDHN May 05, Cleveland’s House
- Diabetes Flow Sheet with Feedback to enhance Guideline Compliance. CDA Edmonton 2005
Continuing Medical Education: (Recent)
- American Diabetes Assoc, Advanced Postgraduate Course, Jan 2001
- American Diabetes Assoc. June 2003
- European Assoc for the study of Diabetes, Budapest Sept 2002
- Canadian Diabetes Assoc. Oct 2003
- International Diabetes Federation; Paris Aug 2003
- American Diabetes Assoc, June 2004
- Canadian Diabetes Assoc, Canadian Soc of Endocrinology & Metabolism, Oct 2004
- American Diabetes Assoc Annual Meeting. San Diego June 2005
- Canadian Diabetes Assoc, Canadian Soc of Endocrinology & Metabolism, Oct 2005
- American Diabetes Assoc Annual Meeting Washington June 2006
- European Assoc for the Study of Diabetes, Copenhagen, Sept 2006
- Canadian Diabetes Assoc, Canadian Soc of Endocrinology & Metabolism, Oct 2006
- International Diabetes Federation, Capetown, Dec 2006
Other Skills & Personal Interests:
- Computers in Medicine
- Diabetes Education Web Site www.diabetesclinic.ca
- Pilot & Aircraft Owner, multi engine, instrument rating, float rating,
- Helicopter & Fixed Wing Commercial Licenses
- Ski Patroller, Mont Tremblant, Que
- Sailing, White Water Kayaking & Canoeing
- Military Service, Canadian Forces, Capt; Rhodesia Defense Force, Major
Articles on the internet:
- 2006 CDA Lipid Guidelines - Commentary [pdf]
- A1c Changes to A1c Derived Average Glucose
- A fun way to remember adequate portions: the Zimbabwe Hand Jive!
- ABC's of Great Diabetes Care
- ACE & ARB in Diabetic Nephropathy
- ACE Inhibitors cut death risk in Half
- ACE Inhibitors Improve Survival of Type 2 Patients
- Advantages of Pump Therapy
- American Diabetes Association (ADA) Clinical Practice Guidelines 2007
- Amylin (Pramlintide) in Diabetes
- An Undisclosed Affair: Sexual Dysfunction In Diabetes
- Animas Price Listing and Ordering Information [pdf]
- Anticoagulant & Inflammatory effect of Statins
- ARB for Hypertension in Diabetics
- Aspirin Conundrum
- Atorvastatin May Improve Endothelial Function
- Auto Control Medical Price Listing and Ordering Information [pdf]
- Avandia and Cardiovascular Safety - Published in The Record News EMC August 17, 2007, and written by J. Robin Conway, M.D. and Ryan Marble, M.D. Candidate
-
Avandia Article: The Controversy Continues (Added June 7, 2007)
- Basal Rates Stickers
- Basic Carbohydrate Counting for Diabetes Management (from CDA CPG 2003)
- Basics of Healthy Eating
- Bibliography of significant articles in Diabetes [html format]
- Bibliography of significant articles in Diabetes [word document]
- Blood pressure monitoring
- Bolus Wizard for Medtronic 722 Insulin Pump
- Calculating Carbohydrates for Recipes which don't have Nutritional Information
- Can drugs be used to prevent Diabetes?
- Can we Prevent Diabetes?
-
Can you reuse insulin syringes?
- Canadian Diabetes Association Lipid Guidelines Sept 2006
- Canadian Diabetes - An Undisclosed Affair: Sexual Dysfunction in Diabetes
- Canadian Lipid Guidelines and Recommendations
- Canadian Lipid guidelines update [pdf]
- Cannabinoid Spray (Sativex) Improves Neuropathic Pain
- Carbohydrate Counting - An Overview
- Carbohydrate Counting - Level 1
- Carbohydrate Counting - Level 2
- Carbohydrate Counting - Level 3
- Carbohydrate Counting Guide - Staying on Target [pdf]
- Carbohydrate Counting Workshop [a www.diabetes.ca reference]
- Carbs and Calories in Common Beer Brands
- Cardiovascular Risk Higher for Women
- Certificate of Medical Necessity for Insulin Pumps
- Certificate of Necessity for Glucose Sensors & supplies [pdf]
- CGMS vs. Capillary Glucose, reasons for variations in readings
- Challenges of Flexible Insulin Therapy
- Choice of Insulin
- Cholesterol and Blood Lipids
- Classification of Diabetic Retinopathy
- Client Selection Criteria for Insulin Pumps
- Clinical Focus: Insulin Pump Therapy [pdf]
- CMAJ Obesity Guidelines 2007 [pdf]
- Combination ACE & ARB Therapy
- Commentary on Avandia from The Wall Street Journal
- Complications & Glucose Levels in Diabetes
- Complications et Mortalité (Presently in French Only)
- Concomitant use of TZDs (Avandia and Actos) and Insulin
- Cost of Continuous Glucose Monitoring
- Daily Blood Glucose Chart
- Dental Diseases and Diabetes
- Diabetes & Blood glucose
- Diabetes and Dementia
- Diabetes drug is safe - An article written by Dr. J. Robin Conway and published in the National Post, September 15 2007
|
|
|
|
|
|
|
|
|
Disclosure
J. Robin Conway, MD
Dr. Conway has received speaker honoraria and research grants in the past year from GlaxoSmithKline, Pfizer, NovoNordisk,
Merck Frosst, sanofi-aventis, AstraZeneca and Servier.
|